Multiple myeloma

December 15, 2021

Now Enrolling: The OPTIMUM clinical trial is studying an additional treatment for patients with multiple myeloma

This trial is for patients who have cancer cells still in the blood or bone marrow after approximately one year of lenalidomide maintenance therapy following a stem cell transplant